Hackernews posts about BioNTech
BioNTech is a German biotechnology company that develops and commercializes immunotherapy treatments, including vaccines and cell therapies, using messenger RNA (mRNA) technology.
- BioNTech Antibody-Drug Demonstrated Clinically Meaningful Efficacy (investors.biontech.de)
- Anthropic buys biotech startup Coefficient Bio in $400M deal (techcrunch.com)
- Curious cases of financial engineering in biotech (www.owlposting.com)
- A four-month FDA delay forced a small biotech company to close its doors (www.statnews.com)
- Lilly bags another in vivo CAR-T biotech via $7B Kelonia deal (www.fiercebiotech.com)
- Longevity Science Is Overhyped. But This Research Could Change Humanity (www.nytimes.com)
- Biopharma R&D pipeline shrinks for first time in 30 years (www.fiercebiotech.com)
- Longevity Science Is Overhyped. But This Research Could Change Humanity (www.nytimes.com)
- Iran strikes leave Amazon availability zones "hard down" in Bahrain and Dubai (www.bigtechnology.com)
- OpenAI Doubling Down on Text Models, Shifting Strategies to Superapp Plan (www.bigtechnology.com)
- OpenAI Pres. Greg Brockman on GPT-5.5 "Spud", Model Moats and 'Compute Economy' (www.bigtechnology.com)
- The AI Data Center Backlash Is Now Impossible to Ignore (www.bigtechnology.com)
- Show HN: Track official AI company news and blogs in your Chrome side panel (chromewebstore.google.com)
- How BioNTech's "revolutionary" lung cancer vaccine works (bigthink.com)
- BioNTech to Host Second AI Day (investors.biontech.de)
- BioNTech founders to depart, form new mRNA-focused company (www.statnews.com)
- BioNTech Provides Strategic Business Update and Outlines 2026 (investors.biontech.de)
- BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership (investors.biontech.de)
- BionTech: Lift of Partial Clinical Hold for BNT326/YL202 (investors.biontech.de)
- BioNTech Receives FDA Fast Track Designation for Antibody-Drug Conjugate (investors.biontech.de)
- BioNTech to Host Innovation Series R&D Day on November 11, 2025 (investors.biontech.de)
- Bristol Myers makes $11B deal with BioNTech to join the cancer-drug race (www.marketwatch.com)
- BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day (www.instadeep.com)
- BioNTech to Host AI Day as an Edition of Its Innovation Series (investors.biontech.de)
- Promising early data in triple negative breast cancer (www.statnews.com)
- Building a global immunotherapy powerhouse translating science into survival (investors.biontech.de)
- Combined flu-Covid vaccine misses a main goal of Phase 3 trial (www.reuters.com)
- Bispecific antibodies that hit key combination of targets in cancer therapy (www.statnews.com)
- Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 (investors.biontech.de)
- Clinically Meaningful Survival Benefit for Patients with Cell Lung Cancer (investors.biontech.de)
- Show HN: BioTradingArena – Benchmark for LLMs to predict biotech stock movements (www.biotradingarena.com)
- PhDs Can't Find Work as Boston's Biotech Engine Sputters (www.wsj.com)
- Where are all the trillion dollar biotechs? (www.ladanuzhna.xyz)
- PhDs Can't Find Work as Boston's Biotech Engine Sputters (www.wsj.com)
- Two Biotech CEOs Convicted in Securities Fraud Scheme (www.justice.gov)